Spectral AI Inc. (MDAI)
NASDAQ (CM) NASDAQ (CM) Primary 
Spectral AI Q1 Earnings Call Highlights
Spectral AI NASDAQ: MDAI said it remains on track toward potential U.S. regulatory clearance and commercialization of its DeepView system for burn assessment, while reporting lower first-quarter research and development revenue tied to the completion of work under a federal contract.
Spectral AI, Inc. (MDAI) Q4 2025 Earnings Call Transcript
Spectral AI, Inc. (MDAI) Q4 2025 Earnings Call Transcript
Spectral AI, Inc. (MDAI) Q2 2025 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Company Participants Dr.Michael DiMaio - Chairman of the Board Sara Prendergast - Corporate Participant Assistant General Counsel - Corporate Participant Vincent Stanley Capone - CFO, General Counsel & Corporate Secretary Conference Call Participants Carl Edward Byrnes - Northland Capital Markets, Research Division John D. Vandermosten - Zacks Small-Cap Research Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Operator Good afternoon, everyone, and welcome to the Spectral AI Inc. Q2 2025 Financial Results Conference Call.
Spectral AI, Inc. (MDAI) Q1 2025 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets John Vandermosten - Zacks Vadim Khalil - SP Angel Operator Good day, and welcome to the Spectral AI, Inc. First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded.
Spectral AI, Inc. (MDAI) Q4 2024 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Michael DiMaio - Chairman Vincent Capone - CFO Jihang Wang - Director of Data Science at Spectral AI Conference Call Participants Carl Byrnes - Northland Capital Markets Ryan Zimmerman - BTIG John Vandermosten - Zacks RK Ramakanth - H.C. Wainwright Operator Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2024 Financial Results Conference Call.
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets RK Ramakanth - H.C. Wainwright John Vandermosten - Zacks Operator Good afternoon, and welcome to the Spectral AI Third Quarter 2024 Financial Results Conference Call.
Spectral AI reports strong Q3 performance, reaffirms FDA submission timeline
Spectral AI Inc (NASDAQ:MDAI) reported a strong financial performance for the third quarter of 2024, highlighted by a 138% increase in research and development revenue as it advanced its burn wound technology. For Q3 2024, the company posted $8.2 million in revenue, up from $3.4 million in the same quarter last year.
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
Spectral AI Inc (NASDAQ:MDAI) announced plans to spin off its subsidiary, Spectral IP, Inc., through a deal with Sauvegarder Investment Management, Inc. (SIM). The transaction aims to position Spectral IP as an independent company with a broader focus on intellectual property (IP) monetization across various sectors, including healthcare, artificial intelligence, and semiconductors.
Spectral AI moves closer to FDA filing for burn wound assessment device
Spectral AI Inc (NASDAQ:MDAI) announced that the final group of patients at burn centers in its US Burn Pivotal Study have completed their clinical visits, with topline results expected in December 2024. This study is expected to be the final clinical trial before Spectral AI seeks Food and Drug Administration (FDA) approval for its DeepView System, a medical device that can assess burn wounds non-invasively.
Spectral AI founder returns as board chairman
Spectral AI Inc (NASDAQ:MDAI) announced that its founder Dr J Michael DiMaio has been appointed chairman of the board of directors. DiMaio, a seasoned cardiothoracic surgeon and former CEO of the company, is expected to lead Spectral AI through its next phase of growth, focusing on the commercialization and FDA approval of its DeepView System for wound care.
Spectral AI completes proof-of-concept for wound measurement technology
Spectral AI Inc (NASDAQ:MDAI) announced the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area of a burn wound. The company said that this technology, now integrated into the company's DeepView System for burn care, offers fast, accurate, and standardized burn size measurements.
Spectral AI reaches key milestone in US burn study, expands clinical trial sites
Spectral AI Inc (NASDAQ:MDAI) announced a significant milestone in its U.S. Burn Pivotal Study with 25% of patient enrollment completed in Emergency Departments (EDs).
